The world of Biolog gets Bigger! Biolog adds contract services and new analysis software to its portfolio of tools with the acquisition of MIDI Labs and MIDI, Inc. January 4, 2023 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI Labs...Read More

November 16, 2022 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial phenotypic profiling and identification products, including the company’s high-throughput OmniLog® system, today announced the launch of new customizable Phenotype MicroArrays™ to further assist Biolog’s customers with metabolic profiling of microbial, mammalian, as well as yeast and fungi cells. Phenotype MicroArrays...Read More

Biolog Announces New Leadership Team and Secures Major Investment to Drive Widespread Adoption of Industry-Leading Microbial Identification and Phenotypic Profiling Products May 12, 2022 — Hayward, CA – Biolog, Inc., a leading provider of cell-based microbial identification and phenotypic profiling technologies, today announced the appointment of a new leadership team including industry veteran Robert Wicke...Read More

Discovery of activation of cancer-fighting T cells by inosine, enabled by Biolog metabolic assay technology Hayward, CA, USA – August 14, 2020 – A multi-site research team headed by Dr. Ruoning Wang at the Nationwide Children’s Hospital has uncovered a metabolic pathway that can potentially be exploited to enhance the killing of anti-cancer T cells...Read More

ALS related metabolic pathway discovered by Sheffield scientists using Biolog technology Discovery could open doorway to new treatment Sheffield, UK and Hayward, CA, USA –February 13, 2019–Researchers at the University of Sheffield have identified a new pathway that is disrupted in amyotrophic lateral sclerosis (ALS), a debilitating and ultimately lethal motor neuron disease (MND). The...Read More